Diffuse large B-cell lymphoma in human T-lymphotropic virus type 1 carriers

Area of Science:

• Oncology
• Virology
• Hematology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
• Human T-lymphotropic virus type 1 (HTLV-1) is associated with various malignancies.
• The role of viral co-infections in DLBCL pathogenesis is an area of ongoing research.

Purpose of the Study:

• To characterize the clinical and pathological features of de novo DLBCL in HTLV-1 carriers.
• To investigate the potential co-occurrence and interaction of Epstein-Barr virus (EBV) in HTLV-1-associated DLBCL.
• To present the first case series on HTLV-1-positive DLBCL patients.

Main Methods:

• Retrospective analysis of seven patients with HTLV-1 carrier status and DLBCL diagnosis.
• Pathological examination including assessment of EBV-encoded RNA (EBER) expression.
• Clinical staging and risk index evaluation.

Main Results:

• Seven HTLV-1 carriers with de novo DLBCL were identified.
• Three of the seven cases tested positive for EBV-encoded RNA (EBER) in tumor cells.
• EBV-positive cases exhibited similar clinical features, including early stage and low-risk indices.

Conclusions:

• This case series highlights the clinical and pathological characteristics of DLBCL in HTLV-1 carriers.
• The co-expression of EBV in a subset of these patients suggests a potential interplay between HTLV-1 and EBV in DLBCL development.
• Further research is warranted to elucidate the relationship between HTLV-1, EBV, and DLBCL.